TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 27, Issue 2, 2010, Pages 131-137

  Kieszko, Robert ^a   Krawczyk, P ^a   Chocholska, S ^a   Dmoszynska A ^a   Milanowski, J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Alleles; Gene polymorphism; Sarcoidosis; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SARCOIDOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651343797     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG Statement on Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
2. Muller-Quemheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-38.
3. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990; 115: 36-42.
4. Agostini C. Cytokine and chemokine blockade as immunointervention strategy for the treatment of diffuse lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 19-22.
5. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J. Sarcoidosis. TNF-α release of alveolar macrophages and serum level of sIL2R are prognostic markers. Am J Respir Crit Care Med 1997; 156: 1586-92.
6. Kanshima H, Nagai S, Tsutsumi T, et al. TNF alpha mRNA, but not IL-I beta, is differentially expressed in lung macrophages of patients with active pulmonary sarcoidosis. Sarcoidosis 1994; 11: 19-25.
7. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-6.
8. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Nco I polymorphism in the first intron of the human TNF-α gene correlates with the variant in amino acid in position 26 and a reduced level of TNF-β production. J Exp Med, 1991, 173: 209-19.
9. Whichelow CE, Hitman GA, Raafat I, Bottazzo GF, Sachs JA. The effect of TNPB gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet 1996; 23 (6): 425-35.
10. Pociot F, Briant L, Jongeneel CV, et al. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-b by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus.. Eur J Immunol 1993; 23: 224-31. (Pubitemid 23031920)
11. Somoskövi A, Zissel G, Seitzer U, Gerdes J, Schlaak M, Müller-Quernheim J. Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999; 11 (11): 882-7.
12. Westendorp R, Langermans J, Huizinga T, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349 (9046): 170-3.
13. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor- concentrations and outcomes of patients with severe sepsis. Crit Care Med 1996; 381-4.
14. Seitzer U, Swider C, Stuber F, et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997; 9: 787-90.
15. Seitzer U, Gerdes J, Müller-Quernheim J. Evidence for disease phenotype associated haplotypes (DR.TNF) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18 (3): 279-83.
16. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65 (2): 163-71.
17. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. Crit Care Med 2003; 31 (1): 211-4.
18. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001; 119 (3): 753-61.
19. Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumor necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008; 151 (2): 251-9.
20. Takashige N, Naruse TK, Matsumori A, et al. Genetic polymorphisms at the tumor necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 1999; 54: 185-90.
21. Swider C, Schnittger L, Bogunia-Kubik K, et al. TNF-alpha and HLA-DR genoryping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999; 10 (2): 143-6.
22. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by MBI restriction of PCR product. Hum Mol Genet 1992; 1 (5): 353.
23. Grutters JC, Sato H, Pantelidis P, et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165 (8): 1119-24.
24. Pandey JP, Frederick M, ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immunol 2002; 63 (6): 485-91.